GoodRx Holdings, Inc. Class A (GDRX) Dividend History

GoodRx Holdings, Inc. Class A (GDRX) is a healthcare technology company that provides consumers with free access to prescription drug price comparisons and discounts. Founded in 2011, it aims to make healthcare more affordable by helping users find lower-cost medication options through its digital platform, including websites and mobile apps. GoodRx collaborates with pharmacies and healthcare providers to offer savings and streamline the medication purchasing process.

2701 Olympic Boulevard, Santa Monica, CA, 90404
Phone: (855) 268-2822
Website: https://www.goodrx.com

Dividend History

GoodRx Holdings, Inc. Class A currently does not pay dividends

Company News

Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets

GoodRx announced a collaboration with Novo Nordisk to offer Ozempic and Wegovy pens at $499/month for eligible self-paying patients, expanding medication access and meeting growing demand for GLP-1 medications.

Benzinga

Featured Companies: HIMS LLY
More Zero-cost Virtual Healthcare Appointments Available to Those Affected by Wildfires in Southern California

Sesame, a healthcare marketplace, is offering no-cost virtual healthcare appointments to Los Angeles residents affected by wildfires, including primary care, prescription refills, and mental health medication management.

GlobeNewswire Inc.

Featured Companies: ABNB TDOC
Why GoodRx Holdings Stock Was Sinking This Week

GoodRx's Q3 2023 earnings missed analyst estimates, with revenue and guidance falling short. The company's stock price dropped nearly 19% as a result, despite growth in key metrics like prescription transactions and monthly active consumers. Increased competition, particularly from Amazon's push into same-day pharmaceutical delivery, is seen as a challenge for GoodRx's future performance.

The Motley Fool

Featured Companies: AMZN
RBC holds firm on GoodRx stock target with Outperform rating - Investing.com

RBC Capital maintained its Outperform rating on GoodRx Holdings Inc. with a steady price target of $10.00. The upcoming quarterly report is anticipated to focus on the growth of Monthly Active Consumers, a key metric for the firm. RBC expects this growth to support GoodRx's guidance of mid-single-digit percentage revenue growth and an EBITDA margin surpassing 30%.

Investing.com

Featured Companies: KR
Wall Street Breakfast: The Week Ahead

Upcoming U.S. retail sales and CPI reports could impact Federal Reserve interest rate cut expectations.

Seeking Alpha

Featured Companies: AGYS AMAT AMC BNED CBRL CHRD CSCO CTRI CVS DE EOSE FLUT GOOG GOOGL GRAB HD HUT IBTA JUNE MFI MSFT MTEN QSR SERV SPIR SPT TGTX TRSG TTWO TWG TWI UAA VITL WMT

Page data last updated 09/07/2025 04:11:53 UTC